Recessive dystrophic epidermolysis bullosa: genes and variants
Explore variant evidence for Recessive dystrophic epidermolysis bullosa across 1 analyzed protein (COL7A1). Linked ClinVar records include 53 pathogenic or likely pathogenic variants, 22 variants of uncertain significance and 36 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Recessive dystrophic epidermolysis bullosa
COL7A1: Collagen alpha-1(VII) chain
It forms anchoring fibrils that secure the epidermal basement membrane to the underlying dermis. Pathogenic variants cause dystrophic epidermolysis bullosa, with skin fragility and scarring ranging from localized disease to severe generalized forms with major complications.
53 ClinVar pathogenic / likely pathogenic and 58 uncertain variants in COL7A1 have source records linked to Recessive dystrophic epidermolysis bullosa. Association strength is not clinical gene validity.
Where Recessive dystrophic epidermolysis bullosa variants cluster
- COL7A1 Triple-helical region (positions 1254–2784): 49 of 53 ClinVar pathogenic / likely pathogenic variants, 1.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Recessive dystrophic epidermolysis bullosa
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL7A1 G1338R | 1338 | Interrupted collagenous region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G1347W | 1347 | Interrupted collagenous region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G1604R | 1604 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G1703E | 1703 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G1815E | 1815 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2049E | 2049 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2233S | 2233 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2351R | 2351 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2366A | 2366 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 C2929F | 2929 | BPTI/Kunitz inhibitor | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2330D | 2330 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2737R | 2737 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2740A | 2740 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 C2929Y | 2929 | BPTI/Kunitz inhibitor | Pathogenic / likely pathogenic (★★) |
| COL7A1 G174R | 174 | VWFA 1 | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2372V | 2372 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2575W | 2575 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2713D | 2713 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2073C | 2073 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2216E | 2216 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2254R | 2254 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2680S | 2680 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2749E | 2749 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2775S | 2775 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 S48F | 48 | VWFA 1 | Pathogenic / likely pathogenic (★★) |
| COL7A1 G2719A | 2719 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 R2628W | 2628 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL7A1 G1299V | 1299 | Interrupted collagenous region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1673E | 1673 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1673R | 1673 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2245D | 2245 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2366C | 2366 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1400S | 1400 | Interrupted collagenous region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2245S | 2245 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1329E | 1329 | Interrupted collagenous region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1489D | 1489 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1507V | 1507 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2218A | 2218 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2333R | 2333 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2342D | 2342 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2357R | 2357 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2542R | 2542 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2683C | 2683 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2692D | 2692 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2701W | 2701 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2734R | 2734 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2025S | 2025 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G2114S | 2114 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 K2309T | 2309 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 G1890S | 1890 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL7A1 R2008L | 2008 | Cell attachment site | Pathogenic / likely pathogenic (★) |
| COL7A1 G1664R | 1664 | Triple-helical region | Pathogenic / likely pathogenic |
| COL7A1 G2590R | 2590 | Triple-helical region | Pathogenic / likely pathogenic |
Which prediction tools work for Recessive dystrophic epidermolysis bullosa
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- ESM1b (LLR): 96 out of 100
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 96 out of 100
- SIFT: 89 out of 100
- CADD: 89 out of 100
- SpliceAI: 61 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Dystrophic epidermolysis bullosa also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Recessive dystrophic epidermolysis bullosa variants (64 pathogenic / likely pathogenic).
- Generalized dominant dystrophic epidermolysis bullosa also has ClinVar records linked to COL7A1 variants; they fall partly in the same places as the Recessive dystrophic epidermolysis bullosa variants (26 pathogenic / likely pathogenic).
- Nonsyndromic congenital nail disorder 8 also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Recessive dystrophic epidermolysis bullosa variants (15 pathogenic / likely pathogenic).
- Dominant dystrophic epidermolysis bullosa with absence of skin also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Recessive dystrophic epidermolysis bullosa variants (12 pathogenic / likely pathogenic).
- Transient bullous dermolysis of the newborn also has ClinVar records linked to COL7A1 variants; they fall mostly in different places as the Recessive dystrophic epidermolysis bullosa variants (10 pathogenic / likely pathogenic).
Diseases related to Recessive dystrophic epidermolysis bullosa
- Dystrophic epidermolysis bullosa, also linked to COL7A1
- Generalized dominant dystrophic epidermolysis bullosa, also linked to COL7A1
- Nonsyndromic congenital nail disorder 8, also linked to COL7A1
- Dominant dystrophic epidermolysis bullosa with absence of skin, also linked to COL7A1
- Transient bullous dermolysis of the newborn, also linked to COL7A1
- Epidermolysis bullosa simplex, dowling-meara, also linked to COL7A1
- Pretibial dystrophic epidermolysis bullosa, also linked to COL7A1
- Epidermolysis bullosa pruriginosa, also linked to COL7A1
- Epidermolysis bullosa, also linked to COL7A1
Frequently asked questions
Which genes have records linked to Recessive dystrophic epidermolysis bullosa?
This view contains 1 analyzed proteins: COL7A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 53 pathogenic or likely pathogenic variants, 22 variants of uncertain significance and 36 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 155 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center